All News

Authorities putting more pressure on supplement manufacturers.

PBMs have a business model where they pay less even while prices go up.

A shortage of mental health-care providers, coupled with pharmacists’ unique skills and access to patients, has led to a significant opportunity for community and health-system pharmacists to aid in detection of depression and in medication selection and counseling for patients with depression.

Community pharmacists fight against financial pressure for their survival.

Cangrealor is the first FDA-approved P2Y12 inhibitor.

How Walgreens is helping pharmacists be more involved than ever in helping cancer patients.

A look at PDMPs in PA-what they are doing and how they are helping patients.

Noctiva is the first agent approved to temporarily decrease urine production in adults with nocturia from various causes.

Former FDA deputy commissioner is nominated to take the top job, but financial ties may bind for him.

A Midwest pharmacy chain is creating an adherence program to help its patients with diabetes.

Celebrate Women's History Month with us! Take a look back to where we have come from and where we still need to go.

How a diabetes clinic that includes a collaboration between an endocrinologist and a pharmacist can produce thousands of dollars in health-care savings.

The conference emphasized the need for standardization and the importance of safety in the training of pharmacy technicians.

Analysts and columnists from the left and right have had time to react to the new healthcare replacement plan. What are they saying?

Jonathan C. Roberts is named Executive Vice President and COO.

Meijer will improve and expand pharmacies across its new and remodeled stores.

A meta-analysis casts light on therapy compliance issues among patients with different mental health disorders.

A new study finds that patients many patients prefer cannabis to prescribed opioids.

If your patients are grumpy on Sundays and happy on Thursdays, you may not be alone.

An ageing population and an increase in government spending mean that NHE will only be growing in the coming decade.

New express lanes are designed to make it easier for customers to quickly fill their prescriptions.

In his address to Congress, Trump hinted at what could be in the future for healthcare reform.

A Pfizer plant in Kansas is putting patients at risk, according to the FDA

Rite Aid and Albertsons expand naloxone Access, hoping to curb the opioid epidemic.

Rare Disease Day is held every year on the last day of February to help spread awareness about rare diseases and the people they impact.

A look at four important drug studies and stories that you need to know about.

How the new Trump administration will affect everything from the ACA to the FDA.

Bills have been introduced in both the Senate and House that are aimed at stopping direct and indirect remuneration fees, assuming they are passed.